福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2010年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/17/11 for the Period Ending 12/31/10 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31 http:/www.e

2、dgar- Copyright 2011,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.Use these links to rapidly review the document TABLE OF CONTENTS PART III Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.2

3、0549 FORM 10-K Commission file number 000-19319 Vertex Pharmaceuticals Incorporated (Exact name of registrant as specified in its charter)Registrants telephone number,including area code(617)444-6100 Securities registered pursuant to Section 12(b)of the Exchange Act:Securities registered pursuant to

4、 Section 12(g)of the Exchange Act:None?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31,2010 or?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Massachus

5、etts 04-3039129(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)130 Waverly Street,Cambridge,Massachusetts 02139-4242(Address of principal executive offices)(Zip Code)Title of Each Class Name of Each Exchange on Which Registered Common Stock,$0.01 Par

6、Value Per Share Rights to Purchase Series A Junior Participating Preferred Stock The NASDAQ Global Select Market Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes?No?Indicate by check mark if the registrant is not required to fi